BIIB ▼ -0.0% - Biogen Inc. $BIIB BIOGEN Q3 ADJ EPS $2.62 VS EST $1.99 -REV $2.80 BLN VS EST $2.63B - LEQEMBI IN-MARKET REVENUE $202M -TOTAL REV EXPECTED TO INCREASE BY A MID-SINGLE DIGIT PERCENTAGE FOR 2026 -FY2026 REV VIEW $10.45B --DATA -OUTLOOK FY ADJ EPS $12.20 TO $13.00 VS EST $12.36 28-OCT-2026 06:06 AM ET